Related Experiment Video
Updated: May 10, 2025
Eye Tracking Young Children with Autism
Published on: March 27, 2012
Increasing Access to Early Diagnosis and Assessment of Autism Via Biomarker-Based Measurements of Social Visual
1Ami Klin, Emory University.
Insights
Early autism diagnosis is crucial but limited. Biomarker-based tools offer objective early autism diagnosis and assessment, improving outcomes for children with autism spectrum disorder.
Area of Science:
- Neurodevelopmental disorders
- Biomarker research
- Pediatric medicine
Background:
- Early diagnosis of autism spectrum disorder (ASD) is critical for intervention, yet only 20% of children receive diagnosis by age 3.
- Limited access to high-quality diagnostic services results in missed opportunities for early intervention.
- Tens of thousands of children annually in the U.S. do not benefit from timely support.
Purpose of the Study:
- To highlight the challenge of delayed autism diagnosis in young children.
- To introduce validated biomarker-based tools for objective early autism diagnosis.
- To advocate for the implementation of these scientific solutions.
Main Methods:
- Review of existing clinical validation and FDA clearance for biomarker-based autism diagnostic procedures.
- Analysis of obstacles to the broad community uptake of these technologies.
Main Results:
- Biomarker-based objective procedures for early autism diagnosis and assessment are clinically validated and FDA-cleared.
- Significant barriers exist in current diagnostic care models hindering widespread adoption.
Conclusions:
- Validated biomarker tools present a significant opportunity to improve early autism diagnosis rates.
- Overcoming entrenched diagnostic care models and prioritizing community needs are essential for successful implementation.
- Widespread adoption of these tools can optimize lifetime outcomes for children with autism spectrum disorder.
Abstract:
Only one in every five children with autism is diagnosed before the age of 3 years. As a result, tens of thousands of children every year in the United States miss benefiting from early interventions and supports that could potentially optimize their lifetime outcomes. A major obstacle is the extremely limited access to high quality diagnosis. To address this challenge, biomarker-based objective procedures for early diagnosis and assessment of autism have already been clinically validated and cleared for broad implementation by the U.S. Food and Drug Administration. Broad community uptake of these science-based solutions, however, will require change in entrenched models of diagnostic care, and aggressive prioritization of the needs of the community at large.
More Related Videos
Related Concept Videos
01:19Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:26Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...